| Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages Y Zhang, N Chirmule, G Gao, R Qian, M Croyle, B Joshi, J Tazelaar, ... Molecular Therapy 3 (5), 697-707, 2001 | 476 | 2001 |
| “Stealth” adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung MA Croyle, N Chirmule, Y Zhang, JM Wilson Journal of virology 75 (10), 4792-4801, 2001 | 298 | 2001 |
| Development of formulations that enhance physical stability of viral vectors for gene therapy MA Croyle, X Cheng, JM Wilson Gene therapy 8 (17), 1281-1290, 2001 | 221 | 2001 |
| Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice MA Croyle, A Patel, KN Tran, M Gray, Y Zhang, JE Strong, H Feldmann, ... PloS one 3 (10), e3548, 2008 | 204 | 2008 |
| PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver MA Croyle, N Chirmule, Y Zhang, JM Wilson Human gene therapy 13 (15), 1887-1900, 2002 | 201 | 2002 |
| Development of a rapid method for the PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions MA Croyle, QC Yu, JM Wilson Human gene therapy 11 (12), 1713-1722, 2000 | 182 | 2000 |
| PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum MA Croyle, SM Callahan, A Auricchio, G Schumer, KD Linse, JM Wilson, ... Journal of virology 78 (2), 912-921, 2004 | 177 | 2004 |
| PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile MA Croyle, HT Le, KD Linse, V Cerullo, G Toietta, A Beaudet, L Pastore Gene therapy 12 (7), 579-587, 2005 | 161 | 2005 |
| Emerging targets and novel approaches to Ebola virus prophylaxis and treatment JH Choi, MA Croyle BioDrugs 27 (6), 565-583, 2013 | 137 | 2013 |
| Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine JS Richardson, MK Yao, KN Tran, MA Croyle, JE Strong, H Feldmann, ... PloS one 4 (4), e5308, 2009 | 136 | 2009 |
| Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus JS Richardson, MK Yao, KN Tran, MA Croyle, JE Strong | 136* | 2009 |
| Factors that influence stability of recombinant adenoviral preparations for human gene therapy MA Croyle, BJ Roessler, BL Davidson, JM Hilfinger, GL Amidon Pharmaceutical development and technology 3 (3), 373-383, 1998 | 97 | 1998 |
| Utility of PEGylated recombinant adeno-associated viruses for gene transfer HT Le, QC Yu, JM Wilson, MA Croyle Journal of controlled release 108 (1), 161-177, 2005 | 89 | 2005 |
| Methods for rapid PEG-modification of viral vectors, compositions for enhanced gene transduction, compositions with enhanced physical stability, and uses therefor M Croyle, JM Wilson US Patent 6,399,385, 2002 | 89 | 2002 |
| Beta cyclodextrins enhance adenoviral-mediated gene delivery to the intestine MA Croyle, BJ Roessler, CP Hsu, R Sun, GL Amidon Pharmaceutical research 15 (9), 1348-1355, 1998 | 88 | 1998 |
| Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola DJ Shedlock, J Aviles, KT Talbott, G Wong, SJ Wu, DO Villarreal, ... Molecular therapy 21 (7), 1432-1444, 2013 | 87 | 2013 |
| Recent advances in Ebolavirus vaccine development JS Richardson, JD Dekker, MA Croyle, GP Kobinger Human vaccines 6 (6), 439-449, 2010 | 86 | 2010 |
| PEGylated adenoviruses: from mice to monkeys P Wonganan, MA Croyle Viruses 2 (2), 468-502, 2010 | 82 | 2010 |
| A single sublingual dose of an adenovirus-based vaccine protects against lethal Ebola challenge in mice and guinea pigs JH Choi, SC Schafer, L Zhang, GP Kobinger, T Juelich, AN Freiberg, ... Molecular pharmaceutics 9 (1), 156-167, 2012 | 71 | 2012 |
| Role of integrin expression in adenovirus-mediated gene delivery to the intestinal epithelium MA Croyle, E Walter, S Janich, BJ Roessler, GL Amidon Human gene therapy 9 (4), 561-573, 1998 | 71 | 1998 |
